FCM
HALO icon

Frontier Capital Management’s Halozyme HALO Stock Holding History

Frontier Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,269,827
Closed -$72.7M – 291
2024
Q3 		$72.7M Buy
1,269,827
+423,600
+50% +$24.3M 0.68% 37
2024
Q2 		$44.3M Buy
846,227
+602,194
+247% +$26.4M 0.44% 85
2024
Q1 		$9.93M Buy
244,033
+66,658
+38% +$2.5M 0.09% 218
2023
Q4 		$6.56M Buy
177,375
+273
+0.2% +$10.3K 0.07% 221
2023
Q3 		$6.77M Buy
177,102
+131,643
+290% +$5.39M 0.07% 218
2023
Q2 		$1.64M Buy
+45,459
New +$1.55M 0.02% 249

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Frontier Capital Management's HALO Position: Q4 2024 in Review

Frontier Capital Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 1,269,827 shares — an estimated $72.7M sold.

Frontier Capital Management first reported a position in HALO in Q2 2023 and held it in 6 quarters. The position peaked at $72.7M in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Frontier Capital Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Frontier Capital Management sold 1,269,827 Halozyme shares in Q4 2024, an estimated $72.7M.
  • Frontier Capital Management first reported a position in Halozyme in Q2 2023 and held it in 6 quarters.
  • Frontier Capital Management's Halozyme position peaked at $72.7M in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Frontier Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.